These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 21734182)

  • 1. GBA-associated PD presents with nonmotor characteristics.
    Brockmann K; Srulijes K; Hauser AK; Schulte C; Csoti I; Gasser T; Berg D
    Neurology; 2011 Jul; 77(3):276-80. PubMed ID: 21734182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial sonography in patients with Parkinson's disease with glucocerebrosidase mutations.
    Kresojević N; Mijajlović M; Perić S; Pavlović A; Svetel M; Janković M; Dobričić V; Novaković I; Lakočević MB; Klein C; Kostić VS
    Parkinsonism Relat Disord; 2013 Apr; 19(4):431-5. PubMed ID: 23332636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].
    Senkevich KA; Miliukhina IV; Beletskaia MV; Gracheva EV; Kudrevatykh AV; Nikolaev MA; Emelyanov AK; Kopytova AE; Timofeeva AA; Yakimovskii AF; Pchelina SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):81-86. PubMed ID: 29171494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric characteristics of GBA-associated Parkinson disease.
    Swan M; Doan N; Ortega RA; Barrett M; Nichols W; Ozelius L; Soto-Valencia J; Boschung S; Deik A; Sarva H; Cabassa J; Johannes B; Raymond D; Marder K; Giladi N; Miravite J; Severt W; Sachdev R; Shanker V; Bressman S; Saunders-Pullman R
    J Neurol Sci; 2016 Nov; 370():63-69. PubMed ID: 27772789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in carriers of glucocerebrosidase gene mutation in Parkinson disease patients.
    Malec-Litwinowicz M; Rudzińska M; Szubiga M; Michalski M; Tomaszewski T; Szczudlik A
    Neurol Neurochir Pol; 2014; 48(4):258-61. PubMed ID: 25168325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features of
    Malek N; Weil RS; Bresner C; Lawton MA; Grosset KA; Tan M; Bajaj N; Barker RA; Burn DJ; Foltynie T; Hardy J; Wood NW; Ben-Shlomo Y; Williams NW; Grosset DG; Morris HR;
    J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):702-709. PubMed ID: 29378790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study.
    Brockmann K; Srulijes K; Pflederer S; Hauser AK; Schulte C; Maetzler W; Gasser T; Berg D
    Mov Disord; 2015 Mar; 30(3):407-11. PubMed ID: 25448271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presenting symptoms of GBA-related Parkinson's disease.
    Kresojević N; Janković M; Petrović I; Kumar KR; Dragašević N; Dobričić V; Novaković I; Svetel M; Klein C; Pekmezović T; Kostić VS
    Parkinsonism Relat Disord; 2015 Jul; 21(7):804-7. PubMed ID: 25957717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.
    Beavan M; McNeill A; Proukakis C; Hughes DA; Mehta A; Schapira AH
    JAMA Neurol; 2015 Feb; 72(2):201-8. PubMed ID: 25506732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of prodromal parkinsonian features in a cohort of
    Avenali M; Toffoli M; Mullin S; McNeil A; Hughes DA; Mehta A; Blandini F; Schapira AHV
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1091-1097. PubMed ID: 31221723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GBA-Associated Parkinson's Disease: Progression in a Deep Brain Stimulation Cohort.
    Lythe V; Athauda D; Foley J; Mencacci NE; Jahanshahi M; Cipolotti L; Hyam J; Zrinzo L; Hariz M; Hardy J; Limousin P; Foltynie T
    J Parkinsons Dis; 2017; 7(4):635-644. PubMed ID: 28777757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
    Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease.
    Török R; Zádori D; Török N; Csility É; Vécsei L; Klivényi P
    Neurosci Lett; 2016 Jan; 610():135-8. PubMed ID: 26547032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
    Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
    Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.
    Thaler A; Bregman N; Gurevich T; Shiner T; Dror Y; Zmira O; Gan-Or Z; Bar-Shira A; Gana-Weisz M; Orr-Urtreger A; Giladi N; Mirelman A
    Parkinsonism Relat Disord; 2018 Oct; 55():45-49. PubMed ID: 29784561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations.
    De Michele G; Palmieri GR; Pane C; Valente EM; Palmieri I; Dello Iacovo CDP; Cuomo N; Giglio A; De Lucia N; Fico T; Perillo S; De Michele G; De Rosa A
    Acta Neurol Belg; 2023 Feb; 123(1):221-226. PubMed ID: 36609835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
    Simuni T; Brumm MC; Uribe L; Caspell-Garcia C; Coffey CS; Siderowf A; Alcalay RN; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Nudelman K; Tosun-Turgut D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten S; Bressman S; Marek K;
    Mov Disord; 2020 May; 35(5):833-844. PubMed ID: 32073681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.
    Jesús S; Huertas I; Bernal-Bernal I; Bonilla-Toribio M; Cáceres-Redondo MT; Vargas-González L; Gómez-Llamas M; Carrillo F; Calderón E; Carballo M; Gómez-Garre P; Mir P
    PLoS One; 2016; 11(12):e0167749. PubMed ID: 28030538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.
    Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Chen-Plotkin A; Van Deerlin VM; Ritz B; Rausch R; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson-Hiller AL; Goldman JG; Stebbins GT; Bernard B; Espay AJ; Revilla FJ; Devoto J; Rosenthal LS; Dawson TM; Albert MS; Tsuang D; Huston H; Yearout D; Hu SC; Cholerton BA; Montine TJ; Edwards KL; Zabetian CP
    Mov Disord; 2016 Jan; 31(1):95-102. PubMed ID: 26296077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
    Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.